secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK:        0000875320
Form:       8-K
Filed at:   2025-05-14T23:59:59+00:00
Accession:  0000875320-25-000194
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vertex shareholders elect all 11 directors, reject golden parachute proposal at 2025 annual meeting
--------------------------------------------------------------------------------

- All 11 director nominees elected with majority support; Bruce Sachs received lowest 'for' votes at 211.6M.
- Ratification of Ernst & Young as auditor for FY2025 passed with 229.4M votes for, 6.9M against.
- Advisory vote on 2024 named executive officer compensation approved: 208.9M for, 17.0M against.
- Shareholder proposal on excessive golden parachutes rejected: 84.1M for, 141.6M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875320/000087532025000194/0000875320-25-000194-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875320/000087532025000194/vrtx-20250514.htm
  HTML page:      https://secwatch.observer/filing/0000875320-25-000194

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer